One day in March last year,
Moose Jaw resident Duncan Blackman came across a pamphlet
on andropause. He says that chance discovery changed his
life.
"My body was deteriorating a lot
faster than I thought it should," he says. He was gaining
weight, his bones seemed frail (he broke his arm three
times), and worst of all his sex drive was "abysmally
low." He couldn't figure out what was up.
After reading about andropause,
everything fell into place. He wasn't just getting older
or having a 'midlife crisis.' It was a hormonal change
thing. He immediately went to his doctor. Since then
the 53-year old psychologist has been popping by the
office for a low dose injection of testosterone every
three weeks.
Duncan credits these shots in his
hips for his newfound energy and libido. His
skin, prone to rashes, has also toughened up and his
beard grows in thicker. He also finds himself more willing
to stand his ground in disputes, although he adds he
hasn't lost his sensitivity: he still writes poetry
and plays the cello when he isn't busy counselling his
patients.
MENOPAUSE
FOR MEN?
The concept that andropause, also known as 'angry male
syndrome,' exists, first emerged in the late 1980s.
Researchers now agree that as men age their testosterone
levels fall, although the hormonal change isn't as dramatic
as what women experience. What's disputed is whether
symptoms ranging from moodiness, low energy levels and
low libido to increased fat, lost bone density and reduced
muscle mass can be tied to this drop in hormone levels
and whether testosterone therapy is an effective
remedy. Or, for that matter, if it explains why some
middle- aged men have affairs with younger women and
buy expensive sports cars.
What's really important isn't just
how much testosterone is in the body, says Dr Jerald
Bain, a staff physician at Mount Sinai Hospital, professor
emeritus at the University of Toronto and president
of the Canadian Society for the Study of the Aging Male,
but what type of testosterone. Past the age of
30, testosterone levels not only drop, but an increasing
amount binds with a protein, making it "biologically
unavailable."
"So while the total diminishes,
the bioavailable testosterone diminishes more drastically,"
says Dr Bain. By age 50, about 20% of men experience
a significant drop in testosterone. But 50% of men will
have significantly reduced amounts of 'bioavailable'
testosterone. "We don't know how many of that 50% are
symptomatic, but we're assuming quite a few are," adds
Dr Bain.
EVIDENCE
IN INFANCY
Others remain sceptical. Dr Mike Evans, a staff physician
at University Health Network of Toronto's Western division
and assistant professor in family and community medicine
at the University of Toronto, says there's still debate
over the exact role testosterone plays, as well as how
to measure it. He worries the label andropause attaches
a 'condition' to a normal life event, much like the
medicalization of menopause. "I'm not sure we should
be actually treating it," he says. "Looking at the evidence,
I just don't think testosterone is a fountain of youth."
Dr Evans says the evidence base
is still in its infancy, pointing out that only one
trial exists with more than 100 patients held over one
year. He also questions the outcome of the trials, which
studied areas ranging from brain activity, physical
strength, mood and sex drive. In some cases, hormone
therapy showed no difference for mood and depression,
and studies on physical strength were similarly inconclusive.
He adds there's no good evidence
it helps for erectile dysfunction, either, and that
other studies have shown a large placebo effect. In
November 2003 the Institute of Medicine concluded, after
a systemic review of testosterone therapy, there was
no clear evidence of health benefits.
So why the hype? Dr Evans blames
the marketing push for two new forms of testosterone
replacement therapy, a patch and a gel.
CANCER
CAUSING?
Negative effects from testosterone therapy include shrinking
testes, blood thickening and sleep apnea, although the
biggest concern is its alleged link to prostate cancer.
Evidence suggests testosterone treatment causes the
prostate to swell, although there's no proven connection
between this and cancer. Dr Bain goes so far as to say
that the testosterone could have a positive impact on
prostate cancer because some candidates for the therapy
have had prostate cancer caught early by check-ups spurred
by their hormone treatment.
Dr Evans remains unconvinced. He
adds that for other andropause-related symptoms, like
depression and osteoporosis, there are much better treatments
than testosterone. "When I walk through the pros and
cons, I don't see any actual advantage for the average
aging male," he says.
But as for Duncan Blackman, he
hasn't experienced any serious side effects and is thoroughly
enjoying what he calls his new lease on life. And so
is his wife. "She likes the new me," he says happily.
|